A Master Introduction to Developing Cell and Gene Therapies
Cell and gene therapies have the potential to be one of the most important advances in effectively treating and controlling disease. While the number of patients receiving cell and gene therapy is quite small compared to other therapeutics, many researchers and manufacturers have started investigating its effects on small populations. There is a lot to consider when creating a study in this area – from study design to regulatory hurdles.
Please note that this webinar was originally run on September 17, 2020.
You are watching a rebroadcast of the webinar. There will not be a live Q&A session following the presentation. If you have any questions for the speakers, please email [email protected]
DISCLAIMER: The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.